Clinical Trials

180 enrolled

Breast Neoplasms, Neoplasm Metastasis

NCT04961632 2024-02-01

Dose-determining and Dose-confirmatory Study to Investigate the Optimal Dose of Tamoxifen in Breast Cancer Patients According to Genotype Status of TCF20 rs932376

Phase 1 Unknown

75 enrolled

Breast Neoplasms

NCT03906669 2023-11-22

WinPro

200 enrolled

Breast Neoplasms

NCT01579734 2023-06-28

HOT

1,884 enrolled

Breast Neoplasms

NCT05800197 2023-04-06

NEMO

Breast Neoplasms

NCT00412022 2023-03-24

HOBOE

1,294 enrolled

Breast Neoplasms

NCT02914158 2023-01-17

ASPAIT

680 enrolled

Breast Neoplasms

NCT04433494 2022-12-07

A Study of TY-302 in Patients With Advanced Solid Tumors

Phase 1 Unknown

60 enrolled

Breast Neoplasms

NCT05501158 2022-08-19

CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population

150 enrolled

Breast Neoplasms

NCT05133674 2022-05-25

Therapeutic Dose Monitoring (TDM) of Tamoxifen

40 enrolled

Breast Neoplasms

NCT02062489 2022-04-27

Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients

688 enrolled

Breast Neoplasms

NCT04852081 2021-04-21

Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.

1,000 enrolled

Breast Neoplasms

NCT04666805 2020-12-14

Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast

1,354 enrolled

Breast Neoplasms, Neoplasm Metastasis, Recurrence

NCT04389424 2020-05-15

NUTRIBREAST

BreastOther

Breast Neoplasms, Nutrition Disorders, Obesity, Vitamin D Deficiency

NCT01758146 2020-03-04

Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

412 enrolled

BreastOther

Breast Neoplasms, Obesity

NCT00541086 2020-02-07

Study of Anastrozole, Letrozole, or Exemestane With or Without Tamoxifen in Treating Postmenopausal Women With Hormone-Responsive Breast Cancer That Has Been Completely Removed By Surgery

3,697 enrolled

Breast Neoplasms

NCT04116827 2019-10-07

Sleep and Activity Patterns in Pre-menopausal Breast Cancer Patients on Tamoxifen Using a Wrist-worn Internet of Things Device

20 enrolled

Breast Neoplasms, Sleep Wake Disorders

NCT03024580 2019-08-15

MEGA

20 enrolled

Breast Neoplasms

NCT04023292 2019-07-17

Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast Cancer

185 enrolled

Breast Neoplasms

NCT03582865 2019-07-08

Genetic Study of CYP2D6 Enzyme and Therapeutic Drug Monitoring of Tamoxifen

100 enrolled

Breast Neoplasms

NCT03137368 2018-10-31

STEP

Breast Neoplasms

NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Phase 2/3 Unknown

200 enrolled

Breast Diseases, Breast Neoplasms

NCT03351062 2017-11-22

Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer

844 enrolled

Breast Neoplasms

NCT03211572 2017-07-07

OTT 17-01

82 enrolled

Breast Neoplasms

NCT02097459 2016-05-25

Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer

600 enrolled

Breast Neoplasms

NCT01503905 2016-05-24

Neoadjuvant Chemotherapy for Operable Premenopausal Breast Cancer Patients

600 enrolled

Amenorrhea, Breast Neoplasms

NCT02488603 2015-07-02

Decision Aids for Tamoxifen Treatment in Breast Cancer Patients

360 enrolled

Breast Neoplasms

NCT00003418 2013-12-19

Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer

4,400 enrolled

Breast Neoplasms

NCT00003678 2013-12-19

Tamoxifen in Treating Women With Breast Cancer

20,000 enrolled

Breast Neoplasms

NCT00010140 2013-12-18

Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer

Breast Neoplasms

NCT00003679 2013-11-06

Combination Chemotherapy in Treating Women With Breast Cancer

350 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00003680 2013-11-06

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00126464 2013-11-06

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

100 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01622361 2013-09-30

NEST

290 enrolled

Breast Neoplasms

NCT00002460 2013-08-07

Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer

Breast Neoplasms

NCT00006030 2013-08-07

Comparison of Four Different Treatment Regimens in Treating Women With Stage I Breast Cancer

Breast Neoplasms

NCT00629278 2013-08-07

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

2,500 enrolled

Breast Neoplasms

NCT00963209 2013-08-02

Tamoxifen Citrate in Patients With Breast Cancer

140 enrolled

Breast Neoplasms

NCT00538330 2011-12-13

Post Operative Adjuvant Chemotherapy Followed by Adjuvant Tamoxifen vs Nil for Patients With Operable Breast Cancer

2,000 enrolled

Breast Neoplasms

NCT00896155 2011-08-30

CONSET

260 enrolled

Breast Neoplasms, Pulmonary Fibrosis

NCT00398489 2010-11-09

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

94 enrolled

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00973037 2009-09-09

ASTRRA-CYP2D6

922 enrolled

Breast Neoplasms

NCT00912548 2009-06-16

ASTRRA

1,234 enrolled

Breast Neoplasms

NCT00003016 2009-02-09

Prolonged Tamoxifen Compared With Shorter Tamoxifen in Treating Patients Who Have Breast Cancer

20,000 enrolled

Breast Neoplasms

NCT00033683 2009-02-09

Combination Chemotherapy in Treating Women With Resected Breast Cancer

Breast Neoplasms

NCT00077168 2009-02-09

Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole

2,000 enrolled